{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:33:37Z","timestamp":1772120017277,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s12149-025-02069-w","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T11:11:00Z","timestamp":1753441860000},"page":"1092-1102","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic value of FDG-PET\/CT findings in mucosal melanoma of the head and neck treated with carbon ion radiotherapy"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3430-7567","authenticated-orcid":false,"given":"Ayako","family":"Hino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobutaka","family":"Mizoguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Koge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryohei","family":"Yaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manatsu","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Matsuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madoka","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoaki","family":"Nagase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harumi","family":"Mochizuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Kakiuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shihyao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yayoi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsunehiro","family":"Doiuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Kurihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,25]]},"reference":[{"issue":"Suppl 1","key":"2069_CR1","first-page":"E1737","volume":"38","author":"D Lombardi","year":"2016","unstructured":"Lombardi D, Bottazzoli M, Turri-Zanoni M, Raffetti E, Villaret AB, Morassi ML, et al. Sinonasal mucosal melanoma: a 12-year experience of 58 cases. Head Neck. 2016;38(Suppl 1):E1737\u201345.","journal-title":"Head Neck"},{"key":"2069_CR2","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1002\/cncr.24976","volume":"116","author":"MA Moreno","year":"2010","unstructured":"Moreno MA, Roberts DB, Kupferman ME, DeMonte F, El-Naggar AK, Williams M, et al. Mucosal melanoma of the nose and paranasal sinuses, a contemporary experience from the M. D. Anderson Cancer Center. Cancer. 2010;116:2215\u201323.","journal-title":"Cancer"},{"key":"2069_CR3","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/alr.21324","volume":"4","author":"BA Tajudeen","year":"2014","unstructured":"Tajudeen BA, Vorasubin N, Sanaiha Y, Palma-Diaz MF, Suh JD, Wang MB. Sinonasal mucosal melanoma: 20-year experience at a tertiary referral center. Int Forum Allergy Rhinol. 2014;4:592\u20137.","journal-title":"Int Forum Allergy Rhinol"},{"key":"2069_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ejca.2020.07.017","volume":"138","author":"P Nenclares","year":"2020","unstructured":"Nenclares P, Ap Dafydd D, Bagwan I, Begg D, Kerawala C, King E, et al. Head and neck mucosal melanoma: the United Kingdom national guidelines. Eur J Cancer. 2020;138:11\u20138.","journal-title":"Eur J Cancer"},{"key":"2069_CR5","doi-asserted-by":"publisher","first-page":"3947","DOI":"10.1200\/JCO.20.00198","volume":"38","author":"R Seth","year":"2020","unstructured":"Seth R, Messersmith H, Kaur V, Kirkwood JM, Kudchadkar R, McQuade JL, et al. Systemic therapy for melanoma: ASCO guideline. J Clin Oncol. 2020;38:3947\u201370.","journal-title":"J Clin Oncol"},{"key":"2069_CR6","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.3390\/cancers16152625","volume":"16","author":"N Mizoguchi","year":"2024","unstructured":"Mizoguchi N, Kano K, Okuda T, Koge H, Shima S, Tsuchida K, et al. Adjuvant therapy with immune checkpoint inhibitors after carbon ion radiotherapy for mucosal melanoma of the head and neck: a case\u2013control study. Cancers. 2024;16:2625.","journal-title":"Cancers"},{"key":"2069_CR7","doi-asserted-by":"publisher","first-page":"7227","DOI":"10.1002\/cam4.2614","volume":"8","author":"Y Takayasu","year":"2019","unstructured":"Takayasu Y, Kubo N, Shino M, Nikkuni O, Ida S, Musha A, et al. Carbon-ion radiotherapy combined with chemotherapy for head and neck mucosal melanoma: prospective observational study. Cancer Med. 2019;8:7227\u201335.","journal-title":"Cancer Med"},{"key":"2069_CR8","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.ijrobp.2016.12.028","volume":"97","author":"M Koto","year":"2017","unstructured":"Koto M, Demizu Y, Saitoh JI, Suefuji H, Tsuji H, Okimoto T, et al. Multicenter study of carbon-ion radiation therapy for mucosal melanoma of the head and neck: subanalysis of the Japan Carbon-Ion Radiation Oncology Study group (J-CROS) study (1402 HN). Int J Radiat Oncol Biol Phys. 2017;97:1054\u201360.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2069_CR9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.anl.2017.03.016","volume":"45","author":"\u015e \u00c7omo\u011flu","year":"2018","unstructured":"\u00c7omo\u011flu \u015e, Polat B, \u00c7elik M, \u015eahin B, Enver N, Kele\u015f MN, et al. Prognostic factors in head and neck mucosal malignant melanoma. Auris Nasus Larynx. 2018;45:135\u201342.","journal-title":"Auris Nasus Larynx"},{"key":"2069_CR10","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/pcmr.13104","volume":"36","author":"JC Thierauf","year":"2023","unstructured":"Thierauf JC, Kaluziak ST, Codd E, Dybel SN, Jobbagy S, Purohit R, et al. Prognostic biomarkers for survival in mucosal melanoma. Pigment Cell Melanoma Res. 2023;36:378\u201387.","journal-title":"Pigment Cell Melanoma Res"},{"key":"2069_CR11","doi-asserted-by":"publisher","first-page":"3316","DOI":"10.1002\/hed.26380","volume":"42","author":"S Flukes","year":"2020","unstructured":"Flukes S, Lohia S, Barker CA, Cracchiolo JR, Ganly I, Patel SG, et al. Primary tumor volume as a predictor of distant metastases and survival in patients with sinonasal mucosal melanoma. Head Neck. 2020;42:3316\u201325.","journal-title":"Head Neck"},{"key":"2069_CR12","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1177\/19458924231177854","volume":"37","author":"D El-Adem","year":"2023","unstructured":"El-Adem D, Yang N, Gudis DA. The role of positron emission tomography for the management of sinonasal malignancies: a systematic review. Am J Rhinol Allergy. 2023;37:593\u2013610.","journal-title":"Am J Rhinol Allergy"},{"key":"2069_CR13","doi-asserted-by":"publisher","first-page":"4420","DOI":"10.3892\/ol.2017.5952","volume":"13","author":"K Shirai","year":"2017","unstructured":"Shirai K, Abe T, Saitoh JI, Mizukami T, Irie D, Takakusagi Y, et al. Maximum standardized uptake value on FDG-PET predicts survival in stage I non-small cell lung cancer following carbon ion radiotherapy. Oncol Lett. 2017;13:4420\u20136.","journal-title":"Oncol Lett"},{"key":"2069_CR14","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1007\/s00259-019-04585-0","volume":"47","author":"S Shrestha","year":"2020","unstructured":"Shrestha S, Higuchi T, Shirai K, Tokue A, Shrestha S, Saitoh JI, et al. Prognostic significance of semi-quantitative FDG-PET parameters in stage I non-small cell lung cancer treated with carbon-ion radiotherapy. Eur J Nucl Med Mol Imaging. 2020;47:1220\u20137.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2069_CR15","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.2967\/jnumed.120.254482","volume":"62","author":"R Nakamoto","year":"2021","unstructured":"Nakamoto R, Zaba LC, Liang T, Reddy SA, Davidzon G, Aparici CM, et al. Prognostic value of bone marrow metabolism on pre-treatment 18F-FDG PET\/CT in patients with metastatic melanoma treated with anti-PD-1 therapy. J Nucl Med. 2021;62:1380\u20133.","journal-title":"J Nucl Med"},{"key":"2069_CR16","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2214\/AJR.14.13575","volume":"205","author":"P Perng","year":"2015","unstructured":"Perng P, Marcus C, Subramaniam RM. (18)F-FDG PET\/CT and Melanoma: staging, immune modulation and mutation-targeted therapy assessment, and prognosis. AJR Am J Roentgenol. 2015;205:259\u201370.","journal-title":"AJR Am J Roentgenol"},{"key":"2069_CR17","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1007\/s00259-020-04757-3","volume":"47","author":"RD Seban","year":"2020","unstructured":"Seban RD, Moya-Plana A, Antonios L, Yeh R, Marabelle A, Deutsch E, et al. Prognostic 18F-FDG PET biomarkers in metastatic mucosal and cutaneous melanoma treated with immune checkpoint inhibitors targeting PD-1 and CTLA-4. Eur J Nucl Med Mol Imaging. 2020;47:2301\u201312.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2069_CR18","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s40644-020-00322-1","volume":"20","author":"CP Reinert","year":"2020","unstructured":"Reinert CP, Gatidis S, Sekler J, Dittmann H, Pfannenberg C, la Foug\u00e8re C, et al. Clinical and prognostic value of tumor volumetric parameters in melanoma patients undergoing 18F-FDG-PET\/CT: a comparison with serologic markers of tumor burden and inflammation. Cancer Imaging. 2020;20:44.","journal-title":"Cancer Imaging"},{"key":"2069_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.796085","volume":"9","author":"A Tanaka","year":"2022","unstructured":"Tanaka A, Sekine T, Ter Voert EEGW, Zeimpekis KG, Delso G, de Galiza BF, et al. Reproducibility of standardized uptake values including volume metrics between TOF-PET-MR and TOF-PET-CT. Front Med. 2022;9: 796085.","journal-title":"Front Med"},{"key":"2069_CR20","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.clon.2022.11.003","volume":"35","author":"AG Abraham","year":"2023","unstructured":"Abraham AG, Riauka T, Hudson M, Ghosh S, Zebak S, Alba V, et al. 18F-fluorodeoxyglucose positron emission tomography parameters can predict long-term outcome following trimodality treatment for oesophageal cancer. Clin Oncol. 2023;35:177\u201387.","journal-title":"Clin Oncol"},{"key":"2069_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104774","volume":"96","author":"JM Placke","year":"2023","unstructured":"Placke JM, Kimmig M, Griewank K, Herbst R, Terheyden P, Utikal J, et al. Correlation of tumor PD-L1 expression in different tissue types and outcome of PD-1-based immunotherapy in metastatic melanoma\u2014analysis of the DeCOG prospective multicenter cohort study ADOREG\/TRIM. EBioMedicine. 2023;96: 104774.","journal-title":"EBioMedicine"},{"key":"2069_CR22","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","volume":"366","author":"SL Topalian","year":"2012","unstructured":"Topalian SL, Hodi FS, Brahmer JR, Gettinger SN, Smith DC, McDermott DF, et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med. 2012;366:2443\u201354.","journal-title":"N Engl J Med"},{"key":"2069_CR23","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.7150\/jca.38689","volume":"11","author":"H Jiang","year":"2020","unstructured":"Jiang H, Zhang R, Jiang H, Zhang M, Guo W, Zhang J, et al. Retrospective analysis of the prognostic value of PD-L1 expression and 18F-FDG PET\/CT metabolic parameters in colorectal cancer. J Cancer. 2020;11:2864\u201373.","journal-title":"J Cancer"},{"key":"2069_CR24","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1097\/MNM.0000000000001136","volume":"41","author":"B Hu","year":"2020","unstructured":"Hu B, Xiao J, Xiu Y, Fu Z, Shi H, Cheng D. Correlation of PD-L1 expression on tumor cell and tumor infiltrating immune cell with 18F-fluorodeoxyglucose uptake on PET\/computed tomography in surgically resected pulmonary adenocarcinoma. Nucl Med Commun. 2020;41:252\u20139.","journal-title":"Nucl Med Commun"},{"key":"2069_CR25","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13550-020-00639-9","volume":"10","author":"X Wu","year":"2020","unstructured":"Wu X, Huang Y, Zhao Q, Wang L, Song X, Li Y, et al. PD-L1 expression correlation with metabolic parameters of FDG PET\/CT and clinicopathological characteristics in non-small cell lung cancer. EJNMMI Res. 2020;10:51.","journal-title":"EJNMMI Res"},{"key":"2069_CR26","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40644-020-00313-2","volume":"20","author":"A Wong","year":"2020","unstructured":"Wong A, Callahan J, Keyaerts M, Neyns B, Mangana J, Aberle S, et al. 18F-FDG PET\/CT based spleen to liver ratio associates with clinical outcome to ipilimumab in patients with metastatic melanoma. Cancer Imaging. 2020;20:36.","journal-title":"Cancer Imaging"},{"key":"2069_CR27","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1007\/s00259-020-04967-9","volume":"48","author":"N Ayati","year":"2021","unstructured":"Ayati N, Sadeghi R, Kiamanesh Z, Lee ST, Zakavi SR, Scott AM. The value of 18F-FDG PET\/CT for predicting or monitoring immunotherapy response in patients with metastatic melanoma: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2021;48:428\u201348.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2069_CR28","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1007\/s00259-023-06243-y","volume":"50","author":"C Sachpekidis","year":"2023","unstructured":"Sachpekidis C, Weru V, Kopp-Schneider A, Hassel JC, Dimitrakopoulou-Strauss A. The prognostic value of [18F]FDG PET\/CT based response monitoring in metastatic melanoma patients undergoing immunotherapy: comparison of different metabolic criteria. Eur J Nucl Med Mol Imaging. 2023;50:2699\u2013714.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2069_CR29","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.jaccao.2020.08.007","volume":"2","author":"K Poels","year":"2020","unstructured":"Poels K, van Leent MMT, Boutros C, Tissot H, Roy S, Meerwaldt AE, et al. Immune checkpoint inhibitor therapy aggravates T cell-driven plaque inflammation in atherosclerosis. JACC Cardio Oncol. 2020;2:599\u2013610.","journal-title":"JACC Cardio Oncol"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-025-02069-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12149-025-02069-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-025-02069-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T12:59:51Z","timestamp":1758373191000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12149-025-02069-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,25]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["2069"],"URL":"https:\/\/doi.org\/10.1007\/s12149-025-02069-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5887618\/v1","asserted-by":"object"}]},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,25]]},"assertion":[{"value":"30 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}